This company has been acquired
Salud financiera de hoja de balance de Satsuma Pharmaceuticals
Salud financiera controles de criterios 4/6
Satsuma Pharmaceuticals has a total shareholder equity of $37.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $43.5M and $5.8M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | US$41.37m |
Patrimonio | US$37.65m |
Total pasivo | US$5.83m |
Activos totales | US$43.48m |
Actualizaciones recientes sobre salud financiera
Can Satsuma Pharmaceuticals (NASDAQ:STSA) Afford To Invest In Growth?
Feb 15Will Satsuma Pharmaceuticals (NASDAQ:STSA) Spend Its Cash Wisely?
Sep 02Here's Why We're Watching Satsuma Pharmaceuticals' (NASDAQ:STSA) Cash Burn Situation
May 13Recent updates
Can Satsuma Pharmaceuticals (NASDAQ:STSA) Afford To Invest In Growth?
Feb 15Will Satsuma Pharmaceuticals (NASDAQ:STSA) Spend Its Cash Wisely?
Sep 02Here's Why We're Watching Satsuma Pharmaceuticals' (NASDAQ:STSA) Cash Burn Situation
May 13Satsuma Pharmaceuticals: Sizing Up This One Trick Pony
Nov 07Satsuma shares surge on data from early-stage STS101 trial
Jun 16Do Institutions Own Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) Shares?
Jan 26Análisis de la situación financiera
Pasivos a corto plazo: STSA's short term assets ($43.4M) exceed its short term liabilities ($5.8M).
Pasivo a largo plazo: STSA has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: STSA is debt free.
Reducción de la deuda: STSA currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: STSA has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: STSA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.4% each year